Disc Medicine to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Oct 31, 2025
WATERTOWN, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at three upcoming investor conferences:
Read more at globenewswire.com
